Imaging Endpoints
Imaging Endpoints is the largest oncology-focused imaging CRO (iCRO), providing customized imaging protocol design, centralized radiologist reads, and AI/radiomics-enabled analysis for pharmaceutical and biotech-sponsored oncology clinical trials across 35+ countries.
- Company typePrivate
- Founded2010
- HeadquartersScottsdale, United States
- Headcount101–250
- GTM typeB2B
- OfferingServices
What Imaging Endpoints does
Imaging Endpoints is a privately-held imaging contract research organization (iCRO) that designs, executes, and analyzes medical imaging for pharmaceutical and biotechnology-sponsored clinical trials, with an exclusive focus on oncology. The company customizes imaging acquisition protocols and analysis criteria (RECIST 1.1, iRECIST, PCWG3, Choi, Lugano, RANO) for each trial, then operates a cloud-based, globally distributed infrastructure spanning 35+ countries and seven offices (Scottsdale HQ, Cambridge, Leiden, Basel, North Harrow, Hyderabad, Shanghai) to deliver real-time reads by credentialed radiologists. Its research arm (Deep Imaging, Tumor Microenvironment, Theragnostic Development, Imaging Biomarkers, 3D Virtual Reconstruction, Big iData) layers radiomics, AI/ML, and quantitative textural analysis (TexRAD) onto standard-of-care imaging to extract additional efficacy signals and to support regulatory submissions.
Imaging Endpoints firmographics
Firmographics- Name
- Imaging Endpoints
- Legal name
- Imaging Endpoints II LLC
- Website
- https://imagingendpoints.com
- Company type
- Private
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Imaging Endpoints is the largest oncology-focused imaging CRO (iCRO), providing customized imaging protocol design, centralized radiologist reads, and AI/radiomics-enabled analysis for pharmaceutical and biotech-sponsored oncology clinical trials across 35+ countries.
- Ownership category
- akta.pro rank
Imaging Endpoints industry classification
Industry- Product category
- Clinical Trial Imaging Services
- NAICS
- Scientific Research and Development Services (5417), Software Publishers (513210)
- SIC
- Services-Health Services (8000)
- akta.pro primary industry
- Imaging Core Labs & Clinical Endpoint Adjudication (HLAGAEAH)
- akta.pro secondary industries
- AI Orchestration & Imaging Analytics Platforms (Model Management/Triage) (HLACALAG), Medical Imaging AI (HDAAAEAH), Imaging Informatics & Workflow (PACS/RIS/VNA) (HLAHABAI)
Keywords
Where Imaging Endpoints is headquartered
LocationHeadquarters
- HQ city
- Scottsdale
- HQ country
- United States
- HQ region
- North America
Offices7 records
Markets served
Imaging Endpoints business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Clinical Trial Imaging Services: Imaging Endpoints provides comprehensive imaging CRO services for clinical trials, specializing in oncology imaging analysis. The company develops and deploys optimal imaging in early-stage trials, advances imaging analysis into late-stage trials, and supports regulatory submissions. Revenue is generated through service contracts with pharmaceutical and biotech companies conducting clinical trials.
Go-to-market motion2 records
Distribution channels1 record
Marketing channels5 records
Imaging Endpoints product offering
Product offeringCore offering
Imaging Endpoints is the largest oncology-focused imaging contract research organization (iCRO) globally. It develops and deploys optimal imaging strategies for early-stage oncology clinical trials, advances imaging analysis into late-stage trials, and supports regulatory submissions for pharmaceutical and biotechnology sponsors. The company delivers centralized imaging review, radiomics analysis, AI/ML-enabled biomarker discovery, and cloud-based infrastructure across more than 35 countries.
Product overview
Imaging Endpoints is the largest oncology-focused imaging CRO (iCRO) offering a comprehensive platform of clinical trial imaging services. The core offering includes Imaging Endpoints Services encompassing Oncology Imaging Services, Rescue Studies, and IT Infrastructure. The platform is enhanced by Research Endpoints services including Deep Imaging, Tumor Microenvironment Analysis, Theragnostic Development, Imaging Biomarkers, 3D Virtual Reconstruction, and Big iData Searchable Databases. The company leverages advanced technologies including radiomics, artificial intelligence, and cloud-based infrastructure to support clinical trials across all phases, operating in over 35 countries with real-time image receipt, query management, and reads for rapid clinical trial decisions.
Differentiator
Problem solved
Functional benefit
Brands
- Clinical Endpoints: Clinical endpoints services brand operated by Imaging Endpoints
- Revolution Endpoints
- Caring Endpoints
Products and services
- Imaging Endpoints Services (Core iCRO Services) World-class scientific expertise and imaging services backed by an industry-leading quality management system for clinical trials across all phases of oncology drug development.
- Oncology Imaging Services Specialized imaging services for oncology clinical trials including customized criteria, radiomics, and artificial intelligence to optimize drug development across multiple cancer types including prostate, breast, lung, hematologic malignancies, and rare diseases.
- Deep Imaging (Research Endpoints) Advanced imaging technologies including additional acquisition sequences, parameters, tumor microenvironment analysis, and advanced post-processing technologies such as Tumor Growth Kinetics and Radiomics with AI.
- Theragnostic Development Research service supporting theranostic and radioligand therapy trials, quantifying whole-body tumor burden, bone marrow involvement, and minimal residual disease using PET and SPECT imaging.
- Imaging Biomarkers Development and validation of imaging biomarkers for clinical trials, including quantitative metrics from radiomic analysis linking imaging with omics enhanced by AI.
- 3D Virtual Reconstruction Advanced imaging visualization service providing three-dimensional reconstructions for enhanced clinical trial analysis.
- Big iData Searchable Databases Comprehensive searchable database of imaging data for research and analysis purposes, supporting big data analysis and radiomics research.
Quantifiable outcome
- 95% marketing authorization success rate
- +3 more outcomes
Companies that use Imaging Endpoints
Customer profileNamed customers4 records
Segments2 records
Ideal customer profiles1 record
Imaging Endpoints technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability11 records
Feature7 records
Imaging Endpoints partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- HonorHealthcoreImaging Endpoints is an affiliate of HonorHealth, one of the largest healthcare systems in the USA. HonorHealth is home to the Virginia G. Piper Cancer Center. This affiliation provides strategic access to clinical expertise and healthcare infrastructure.
- Southwest Medical Imaging, Ltd. (SMIL/RadPartners)coreImaging Endpoints is an affiliate of Southwest Medical Imaging, Ltd. (SMIL/RadPartners), ranked as the largest private radiology group in the USA. This partnership provides access to extensive radiology expertise and infrastructure.
- Scientific Advisory Board MemberscoreImaging Endpoints has a Scientific Advisory Board including world-class radiologist Elliot K. Fishman from Johns Hopkins Hospital to help guide imaging efforts. The board provides expert guidance on imaging science and clinical trial strategies.
Scale indicators7 records
Recent moves9 records
Expansion highlights4 records
Imaging Endpoints competitors and assessment
Company assessmentBroad incumbents
- IQVIA: IQVIA is the world's largest CRO with broad imaging capabilities embedded in its clinical operations offering. As a broad incumbent, it competes with IE on large, multi-modality oncology trials where sponsors prefer a single-vendor solution, though its imaging expertise is less specialized than IE's.
- ICON plc: ICON is a top-tier global CRO with an imaging core lab offering acquired through its PRDO and other transactions. As a broad incumbent, it competes with IE on integrated imaging-plus-operations trial delivery for large pharma sponsors.
- Medpace: Medpace is a mid-to-large global CRO with growing imaging capabilities serving oncology and other therapeutic areas. It is a broad incumbent competing with IE for oncology trial work, particularly with mid-sized biotech sponsors.
- Parexel: Parexel is a large global CRO with imaging and biomarker services for clinical trials. As a broad incumbent, it offers sponsors integrated clinical operations plus imaging, putting competitive pressure on specialty imaging CROs like IE.
Direct peers
- WorldCare Clinical (WCG): WorldCare Clinical (now part of WCG) is an imaging CRO providing independent image review and centralized imaging services for clinical trials, with a particular focus on oncology and ophthalmology. It directly competes with IE for pharma-sponsored imaging work.
- Clario (formerly ERT/Bioclinica): Clario (formed from the merger of ERT and Bioclinica) is a leading imaging core lab and eCOA/eClinical provider serving clinical trials globally. It is the most direct competitor to Imaging Endpoints in oncology imaging core lab services, with comparable offerings in centralized imaging review, radiomics, and multi-modality oncology trial support.
- Invicro: Invicro is a specialized imaging CRO providing PET, MRI, and radiomics services for clinical trials, with deep expertise in neuroimaging and oncology. It directly competes with IE on imaging core lab services, AI-enabled image analysis, and biomarker development for pharma/biotech sponsors.
- Calyx (formerly BioClinica/Molecular Imaging): Calyx (formerly the Molecular Imaging business of BioClinica) provides medical imaging management and AI-enabled image analysis for clinical trials, with a strong oncology and neuroscience focus. It is a direct peer in imaging CRO services for pharma and biotech sponsors.
- Pharmtrace: Pharmtrace is a specialized imaging CRO focused on CNS and oncology clinical trials, providing centralized imaging review and advanced image analysis. It is a direct peer in the imaging core lab niche that competes with IE for biomarker-driven oncology imaging work.
Emerging players
- Bayer Radiology / Median Technologies: Median Technologies is an emerging imaging CRO/AI vendor providing iCRO and imaging AI services for oncology clinical trials. It competes with IE for sponsor work in AI-driven oncology imaging analysis, with a particular focus on iBiopsy and iCRO offerings.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Imaging Endpoints social profiles
Digital presenceImaging Endpoints compliance and trust
Trust signalCompliance2 records
Imaging Endpoints financial estimates
Financial estimateRevenue estimate
Valuation estimate
Imaging Endpoints leadership team
Management profileNumber of profiles
Profiles8 records
Imaging Endpoints funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Imaging Endpoints M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Imaging Endpoints
What does Imaging Endpoints do?
Imaging Endpoints is the largest oncology-focused imaging contract research organization (iCRO) globally. It develops and deploys optimal imaging strategies for early-stage oncology clinical trials, advances imaging analysis into late-stage trials, and supports regulatory submissions for pharmaceutical and biotechnology sponsors. The company delivers centralized imaging review, radiomics analysis, AI/ML-enabled biomarker discovery, and cloud-based infrastructure across more than 35 countries.
Is Imaging Endpoints a public or private company?
Imaging Endpoints is a private company. It is classified as corporate owned and is currently operating.
When was Imaging Endpoints founded?
Imaging Endpoints was founded in 2010. It employs 101 to 250 people.
Where is Imaging Endpoints based?
Imaging Endpoints is headquartered in Scottsdale, United States, in the North America region.
How does Imaging Endpoints make money?
One revenue line is on record: clinical Trial Imaging Services.
Who are Imaging Endpoints's main competitors?
Broad incumbents on record are IQVIA, ICON plc, Medpace and Parexel. Direct peers are WorldCare Clinical (WCG), Clario (formerly ERT/Bioclinica), Invicro, Calyx (formerly BioClinica/Molecular Imaging) and Pharmtrace. Bayer Radiology / Median Technologies is listed as an emerging player.
Does Imaging Endpoints have an API?
No public API is recorded for Imaging Endpoints.
What industry is Imaging Endpoints in?
Imaging Endpoints's product category is Clinical Trial Imaging Services. Its primary akta.pro industry code is HLAGAEAH, Imaging Core Labs & Clinical Endpoint Adjudication, with a secondary code of HLACALAG, AI Orchestration & Imaging Analytics Platforms (Model Management/Triage). Its NAICS code is 5417 and its SIC code is 8000.